top of page

CANCER GENE THERAPY

e-School Series 6


Directing the immune response to specific tumor antigens using modified oncolytic viruses Vincenzo Cerullo, University of Helsinki






Oncolytic virotherapy

Stephen Russell, Mayo Clinic, Rochester







Updates with engineered T cells

Carl June, Upenn, Philadelphia

VIDEO AVAILABLE FOR ESGCT MEMBERS ONLY


Cancer immunotherapy: beyond CAR T cells

Chiara Bonini, IRCCS Ospedale San Raffaele

Comments


bottom of page